Jeanette Rothwell
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Journal: European urology
Published: October 23, 2025
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
Journal: BJU international
Published: June 05, 2024
Hereditary renal cancer patient and public involvement group: A collaborative, consensus decision process to develop a communication tool for patient use.
Journal: Journal of clinical and translational science
Published: August 24, 2022
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.
Journal: The Lancet. Oncology
Published: July 02, 2021
Psychosocial effects of whole-body MRI screening in adult high-risk pathogenic TP53 mutation carriers: a case-controlled study (SIGNIFY).
Journal: Journal of medical genetics
Published: June 27, 2019
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Journal: European urology
Published: November 03, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026